Energy Production and Utilization by Human Platelets in the Presence of Some Guanidines and Phenols (Uremic Toxins) that Inhibit Aggregation

Summary

Platelet aggregation induced by ADP can be inhibited by plasma from uremic patients or by toxins isolated from their plasma, e. g. guanidinosuccinic acid, methylguanidine, phenol and hydroxyphenylacetic acids. Since these chemical substances can interfere with energy metabolism in tissues other than platelets and since ATP production is needed for ADP-induced aggregation, alterations in platelet energy metabolism could underlie excessive bleeding in uremic patients. Platelets incubated with idioacetate and deprived of anaerobic glycolysis produced the same quantity of ATP through respiration in the presence of all the uremic toxins studied as in their absence. Similarly, platelets incubated with cyanide and deprived of the oxidative pathway utilized anaerobic glycolysis to produce normal quantities of ATP in the presence of all the uremic toxins. The utilization of ATP, as indicated by active transmembrane potassium transport, was also unaffected by the above listed guanidines and phenols. It is concluded that the in vitro inhibition of ADP-induced platelet aggregation by the guanidines and phenols studied is not due to inhibition of production or utilization of ATP.

• References

• 1 Booyse F. M, and Rafelson Jr. M. E. 1972; Regulation and Mechanism of Platelet Aggregation. Annals of the New York Academy of Sciences 201: 37.
• 2 Chambers D. A, Salzman E. W, and Neri L. L. 1967; Characterization of “Ecto-ATPase” of Human Blood Platelets. Archives of Biochemistry and Biophysics 119: 1973.
• 3 Doeey Gr. J. C, Hirsch J, and DeGruchy G. C. 1970; Platelet Metabolism and Function. Haematologica 4: 405.
• 4 Glovannetti S, Blagni M, Balestri P. L, Navalesi P, Glagnoni P, Dematteis A, Ferro-Milone P, and Perfetti C. 1969; Uraemia-like Syndrome in Dogs Chronically Intoxicated with Methyl-Guanidine and Creatinine. Clinical Science 36: 445.
• 5 Gorstein F, Carroll H. J, and Puszkin E. 1967; Electrolyte Concentrations, Potassium Flux Kinectics, And the Metabolic Dependence of Potassium Transport in Human Platelets. Journal of Laboratory and Clinical Medicine 70: 938.
• 6 Hicks J. M, Youngs D. S, and Wootton I. D. P. 1964; The Effect of Uremic Blood Constituents on Certain Cerebral Enzymes. Clinica Chemica Acta 9: 228.
• 7 Hollunger G. 1955 Guanidines and Oxidative Phosphorylation. Acta, pharmacologica et toxicológica (Kbh.) II. Suppl. I.
• 8 Horowitz H. I, Cohen B. D, Martinez P, and Papayoanov M. 1967; Defective ADP-induced Platelet Factor 3 Activation in Uremia. Blood 30: 331.
• 9 Lascelles P. T, and Taylor W. H. 1966; The Effect Upon Tissue Respiration in vitro of Metabolites which Accumulate in Uraemic Coma. Clinical Science 31: 403.
• 10 Maurin B. 1969. Blood Platelets in Man and Animals. Pergamon Press; Braunschweig:
• 11 O’Brien J. R. 1966; Changes in Platelet Membranes Possibly Associated with Platelet Stickiness. Nature 211: 1057.
• 12 Quastel J. H, and Woolrldge W. R. 1928; Some properties of the Dehydrogenating Enzymes of Bacteria. Biochemical Journal 22: 689.
• 13 Rabiner S. F. 1972; The Effect of Dialysis on Platelet Function of Patients with Renal Failure. Annals of the New York Academy of Science 201: 234.
• 14 Rabiner S. F, and Molinas F. 1970; The Role of Phenol and Phenolic Acid and Its Role in Uremic Bleeding. American Journal of Medicine 49: 336.
• 15 Renner D, and Heinz R. 1965; Oxygen Consumption and Utilization of Carbohydrate and Fat in Kidney Cortex Slices and Brain Homogenate Using Sera of Chronic Uraemic Patients. Proc. Europ. Dial. Transpl. Assoc 2: 121.
• 16 Spaet R. and Lejnieks 1966; Studies on the Mechanism Whereby Platelets are Clumped by ADP. Thrombosis et Diathesis Hemorrhagica 15: 36.
• 17 Stewart J. H, and Castaldi P. A. 1967; Uremic Bleeding: A Reversible Platelet Defect Corrected by Dialysis. Quarterly Journal of Medicine 36: 409.